References
- MorimotoIEdmistonAHortonRAlteration in the metabolism of dihydrotestosterone in elderly men with prostate hyperplasiaJ Clin Invest19806636126153716921:STN:280:DyaL3c3kvF2itg%3D%3Dhttps://doi.org/10.1172/JCI1098956156957
- VermeulenAClinical review 24: androgens in the aging maleJ Clin Eendocrinol Metab19917322212241:STN:280:DyaK3MzhtVOnsA%3D%3Dhttps://doi.org/10.1210/jcem-73-2-221
- NieschlagESwerdloffRBehreHMGoorenLJKaufmanJMLegrosJJLunenfeldBMorelyJESchulmanCWangCWeidnerWWuFCInvestigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendationsJ Androl20062721351371:STN:280:DC%2BD28%2Fos1GgtA%3D%3Dhttps://doi.org/10.2164/jandrol.0504716474020
- HongBSAhnTYRecent trends in the treatment of testosterone deficiency syndromeInt J Urology2007149819851:CAS:528:DC%2BD1cXjs1WmtA%3D%3Dhttps://doi.org/10.1111/j.1442-2042.2007.01882.x
- WangCSwerdloffREditorial: Should the nonaromatizable androgen dihydrotestosterone be considered as an alternative to testosterone in the treatment of the andropause?J Clin Endocrinol Metab2002874146214661:CAS:528:DC%2BD38XivFKlsbs%3Dhttps://doi.org/10.1210/jcem.87.4.848811932265
- ChenJKimJDaltonJTDiscovery and therapeutic promise of selective androgen receptor modulatorsMol Interv20055317318820728771:CAS:528:DC%2BD2MXmvVakt7w%3Dhttps://doi.org/10.1124/mi.5.3.715994457
- WalrandSBoirieYOptimizing protein intake in aging. Current opinionClin Nut Met Care2005889941:CAS:528:DC%2BD2MXhsVyltb0%3Dhttps://doi.org/10.1097/00075197-200501000-00014
- Movérare-SkrticSVenkenKAnderssonNLindbergMKSvenssonJSwansonCVanderschuerenDOscarssonJGustafssonJAOhlssonCDihydrotestosterone treatment results in obesity and altered lipid metabolism in orchidectomized miceObesity Research2006144662672https://doi.org/10.1038/oby.2006.75
- MontieJEPientaKJReview of the role of androgenic hormones in the epidemiology of benign prostatic hyperplasia and prostate cancerUrology19944368928951:STN:280:DyaK2c3lsF2qtg%3D%3Dhttps://doi.org/10.1016/0090-4295(94)90163-57515207
- StrauchGPerlesPVergultGGabrielMGibelinBCummingsSMalbecqWMaliceMPComparison of finasteride (Proscar) and serenoa repens Permixon) in the inhibition of 5-alpha reductase in healthy male volunteersEur Urol1994262472521:STN:280:DyaK2M7gsValtA%3D%3D7805711
- StaimanVRLoweFCTamoxifen for flutamide/finasteride-induced gynecomastiaUrology19975069299331:STN:280:DyaK1c%2FovVWgsw%3D%3Dhttps://doi.org/10.1016/S0090-4295(97)00457-39426725
- AndersonMLA preliminary investigation of the enzymatic inhibition of 5α-reductase and growth of prostatic carcinoma cell line LNCap-FGC by natural astaxanthin and saw palmetto lipid extract in vitro J Herbal Pharm20055117261:CAS:528:DC%2BD2MXhtFGrsbzLhttps://doi.org/10.1080/J157v05n01_03
- Anderson ML: Method of inhibiting aromatase with specific dietary supplements. U.S. Patent application # 20040156926, 2004 Triarco Industries, Inc
- MorleyJEKaiserFRaumWJPerryRHFloodJFJensenJSilverAJRobertsEPotentially predictive and manipulatable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormoneProc Natl Acad Sci USA19979475377542238571:CAS:528:DyaK2sXksFygsbg%3Dhttps://doi.org/10.1073/pnas.94.14.75379207127